AI assistant
Sending…
Bionano Genomics, Inc. — Director's Dealing 2018
Dec 28, 2018
35041_dirs_2018-12-28_2af66190-6f62-47f8-b678-531543a80aa1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2018-08-21
Reporting Person: Wealth Strategy Holding Ltd (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 975000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant | $6.125 | 2023-08-20 | Common Stock (9750000) | Direct |
More from Bionano Genomics, Inc.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 2
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18